ISPC News and Press, iSpecimen Inc. From 12/09/21

Ensysce Biosciences (NASDAQ:ENSC) +83%. Inspira Technologies (NASDAQ:IINN) +59%. American Virtual Cloud Technologies (NASDAQ:AVCT) +29% announces significant projected revenue growth of Kandy, its cloud communications platform. Siyata Mobile (NASDAQ:SYTA) +28%. Digital Brands (NASDAQ:DBG...

Celyad Oncology (NASDAQ:CYAD) +31% raises $32.5M in private placement with Fortress Investment Group. Longeveron (NASDAQ:LGVN) +26% on FDA orphan designation to Lomecel-B Marvell Technology (NASDAQ:MRVL) +22% after third-quarter earnings beat Code Chain New Continent ...

iSpecimen Expands Supplier Network of Human Biospecimens to Help Advance Research in Neurological Disorders Growth of global biospecimen supply network opens access to essential tissue, biofluids, and cells needed to support research in Alzheimer's disease, Parkinson's, and othe...

iSpecimen Inc. Announces Closing of Approximately $21 Million Private Placement PR Newswire LEXINGTON, Mass. , Dec. 1, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens ...

iSpecimen Inc. (NASDAQ:ISPC) traded today at a new 52-week high of $28.96. Approximately 13.3 million shares have changed hands today, as compared to an average 30-day volume of 5 million shares. In the past 52 weeks, iSpecimen Inc. share prices are bracketed by a low of $4.75 and a high...

iSpecimen (ISPC +29.9%), which has been on a roll since Nov. 22, is continuing its hot streak. Between the market open on Nov. 22 and early this afternoon, shares have risen ~119%. The company benefitted last week from a contract with the U.S. government and several private researchers f...

Gainers: Krystal Biotech (NASDAQ:KRYS) +118%, Petros Pharmaceuticals (NASDAQ:PTPI) +96%, Adagio Therapeutics (NASDAQ:ADGI) +69%, iSpecimen (NASDAQ:ISPC) +50%, cbdMD (NYSE:YCBD) +31%. Losers: Fennec Pharmaceuticals (NASDAQ:FENC) -51%,...

180 Life Sciences (NASDAQ:ATNF) has added ~18.3%, and Vaxart (NASDAQ:VXRT) gained ~5.4% in early trading as the two biotechs have sparked significant investor interest on social media platforms. According to data tracking the mentions of ticker symbols on social media, bot...

iSpecimen (NASDAQ:ISPC) has entered into a securities purchase agreement with three investors for the sale of ~1.75M shares of common stock together with warrants to purchase ~1.3M shares in a private placement, for gross proceeds ~$21M. Each share of common stock and accompanying three-...

iSpecimen Inc. Announces $21 Million Private Placement PR Newswire LEXINGTON, Mass. , Nov. 29, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) ("iSpecimen" or the "Company"), an online marketplace for human biospecimens , today announced that it has en...